Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapsone for pain relief in knee osteoarthritis
IRCT20151126025252N2Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Jul 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of dapsone in knee osteoarthritis (OA) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Change in pain score by Visual Analog Scale and Change in WOMAC score. Started Jul 2024; status: completed.
02
Drugs
dapsone
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20151126025252N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151126025252N2.